1 |
Drug |
Oncology |
Renal cell carcinoma |
Phase III |
2 |
Drug |
Pulmonology |
Pneumococcal Conjugate Vaccine |
Phase III |
3 |
Drug |
Oncology |
NSCLC |
Phase I, II, IV, EAP |
4 |
Drug |
Gastroenterology |
Intestinal disorder |
Phase IV |
5 |
Drug |
Cardiology |
Hypertension |
IIT |
6 |
Drug |
Dermatology |
Androgenetic alopecia |
Phase IV |
7 |
Drug |
Endocrinology and Metabolism |
Type II DM |
IIT |
8 |
Drug |
Endocrinology and Metabolism |
Type I DM |
IIT |
9 |
Drug |
Hematology |
CML |
Phase II, IV |
10 |
Drug |
Obstetrics & Gynecology |
Postmenopausal Patient |
Phase III |
11 |
Drug |
Gastroenterology |
Type B hepatitis |
Phase IV |
12 |
Drug |
Cardiology |
Cardiovascular events |
Phase IV |
13 |
Drug |
Nephrology |
Renal allograft recipients |
Phase IIIb |
14 |
Drug |
Oncology |
Cancer pain |
Phase IV |
15 |
Drug |
Oncology |
Solid tumor |
Phase I |
16 |
Drug |
Oncology |
Cancer |
Phase II, IV |
17 |
Drug |
Cardiology |
Cardiovascular disease |
Phase IV |
18 |
Drug |
Oncology |
Colorectal cancer |
Phase II, IIT |
19 |
Cell therapy |
Oncology |
Colon cancer |
Phase I, II |
20 |
Cell therapy |
Oncology |
Lung cancer |
Phase I, II |